BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 19, 2010
View Archived Issues
Preclinical and clinical data presented on antibiotic CB-183315
Read More
Lundbeck describes new neuropeptide Y5 receptor antagonists
Read More
U.S. scientists claim new MAPK 8 inhibitors
Read More
MorphoSys and Proteros Biostructures receive grant to develop new technology platform
Read More
Biotie regains rights to phosphodiesterase 10 inhibitors for CNS disorders
Read More
Phase I data reported on Zealand Pharma's ZP-1848 in Crohn's disease
Read More
Phase I trials assess safety, tolerability and pharmacokinetics of ASM-024
Read More
DCVax-L is well tolerated combined with other anticancer agents in ovarian cancer
Read More
PEGylated opioid analgesic NKTR-181 demonstrates slowed entry into CNS
Read More
Tekmira receives grant to develop RNAi agents against Ebola and Marburg virus infections
Read More
Genmab reports feedback from U.S. and E.U. authorities on zalutumumab
Read More
EC grants orphan drug status for pralatrexate in Hodgkin's lymphoma
Read More
Labopharm and Paladin Labs enter agreements on pain medications
Read More
Amgen reviews TREAT data and proposes updates to ESA labeling
Read More
New protein kinase inhibitors identified by sanofi-aventis
Read More
FDA approves ISTA's sNDA for bromfenac ophthalmic solution Bromday
Read More
Inhibitex completes enrollment in phase II FV-100 trial in shingles
Read More
New inhibitors of dual specificity protein kinase TTK claimed
Read More
Glenmark Pharmaceuticals patents new TRPA1 modulators
Read More
FDA approves Botox as treatment for chronic migraine
Read More
Celgene acquires Abraxis BioScience
Read More
EMA grants orphan drug status for forodesine in chronic lymphocytic leukemia
Read More
Phosphagenics to advance TPM oxycodone patch
Read More
New selective serine/threonine-protein kinase 6 inhibitors discovered
Read More
Levetiracetam does not improve cerebellar symptoms of multiple sclerosis
Read More